BrightSpring Health Services Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $14.4B+42.7% YoYTTM through 30 Jun 2026
Net Income $366MTTM through 30 Jun 2026
Free Cash Flow $402.4MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 11.8% |
| EBITDA Margin | 4.2% |
| Operating Margin | 2.3% |
| Net Margin | 2.6% |
Returns
10.1%ROE
1.6%ROA
9.9%ROIC
Balance Sheet Health
Debt / Equity1.34x
Current Ratio1.57x
Net Debt$2.4B
Cash & Equivalents$550.4M
Quality Metrics
Altman Z-Score4.55
Piotroski F-Score6 / 9
FCF Margin2.8%
Rule of 409.7
Earnings-Beat Rate75.0%
Multi-Year Trend
RevenueFY2025: $12.9B
Diluted EPS$1.65TTMFY2025: $0.87
Dividend
No dividend
Capital Allocation
Capex Intensity0.7%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Pharmacy Solutions | $11.4B | +30.8% | View detailsExpected to continue strong growth driven by oncology and rare/orphan drug pipelines. |
| Provider Services | $1.5B | +11.2% | View detailsFocusing on home health, hospice, and primary care expansion, leveraging pharmacy network integration. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.